[ Pobierz całość w formacie PDF ]
Force on Alzheimer s Disease. Neurology 1984; 34: current version and scoring rules. Neurology 1993; 43:
939-944. 2412-2414.
47. World Health Organization: The ICD-10 Classifica- 66. Shay K.A., Duke L.W., Conboy T. i wsp.: The clinical
tion of Mental and Behavioural Disorders: Diagnostic validity of the Mattis Dementia Rating Scale in stag-
Criteria for Research. Geneva, WHO 1993. ing Alzheimer s dementia. J. Geriatr. Psychiatry
48. American Psychiatric Association. Desk reference to Neurol. 1991; 4: 18-25.
Diagnostic Criteria from DSM-IV. Washington, DC: 67. Dahlke F., Lohaus A., Gutzmann H.: Reliability and
APA 1994. clinical concepts underlying global judgments in de-
49. Petersen R.C., Doody R., Kurz A. i wsp.: Current con- mentia: implications for clinical research. Psychophar-
cepts in mild cognitive impairment. Arch. Neurol. 2001; macol. Bull. 1992; 28: 425-432.
58: 1985-1992. 68. Rockwood K., Joffres C.: Improving clinical descrip-
50. Larrieu S., Letenneur L., Orgogozo J.M. i wsp.: Inci- tions to understand the effects of dementia treatment:
dence and outcome of mild cognitive impairment in consensus recommendations. Int. J. Geriatr. Psychiatry
a population-based prospective cohort. Neurology 2002; 2002; 17: 1006-1011.
59: 1594-1599. 69. Folstein M.F., Folstein S.E., McHugh P.R.: Mini-men-
51. Linn R.T., Wolf P.A., Bachman D.L. i wsp.: The pre- tal state . A practical method for grading the cogni-
clinical phase of probable Alzheimer s disease. A 13- tive state of patients for the clinician. J. Psychiatr. Res.
year prospective study of the Framingham cohort. Arch. 1975; 12: 189-198.
Neurol. 1995; 52: 485-490. 70. Rosen W.G., Mohs R.C., Davis K.L.: A new rating
52. Devanand D.P., Jacobs D.M., Tang M.X. i wsp.: The scale for Alzheimer s disease. Am. J. Psychiatry 1984;
course of psychopathologic features in mild to mod- 141: 1356-1364.
erate Alzheimer disease. Arch. Gen. Psychiatry 1997; 71. Reisberg B., Finkel S., Overall J. i wsp.: The Alzhei-
54: 257-263. mer s disease activities of daily living international
53. Marin D.B., Green C.R., Schmeidler J. i wsp.: Non- scale (ADL-IS). Int. Psychogeriatr. 2001; 13: 163-181.
cognitive disturbances in Alzheimer s disease: frequen- 72. Gélinas I., Gauthier L., McIntyre M., Gauthier S.: De-
cy, longitudinal course, and relationship to cognitive velopment of a functional measure for persons with
symptoms. J. Am. Geriatr. Soc. 1997; 45: 1331-1338. Alzheimer s disease: the disability assessment for de-
54. Levy M.L., Cummings J.L., Fairbanks L.A. i wsp.: mentia. Am. J. Occup. Ther. 1999; 53: 471-481.
Longitudinal assessment of symptoms of depression, 73. Cummings J.L., Mega M., Gray K. i wsp.: The Neuro-
agitation, and psychosis in 181 patients with Alzhei- psychiatric Inventory: comprehensive assessment of psy-
mer s disease. Am. J. Psychiatry 1996; 153: 1438-1443. chopathology in dementia. Neurology 1994; 44: 2308-
55. K³oszewska I.: Incidence and relationship between be- -2314.
havioural and psychological symptoms in Alzheimer s 74. Reisberg B., Borenstein J., Salob S.P. i wsp.: Behavior-
disease. Int. J. Geriatr. Psychiatry 1998; 13: 785-792. al symptoms in Alzheimer s disease: phenomenology
56. Bronstein Y.L., Cummings J.L.: Neuropsychiatric ma- and treatment. J. Clin. Psychiatry 1987; 48 (supl.): 9-15.
nifestations of dementia. W: Gauthier S., Cummings J.L. 75. Tariot P.N.: CERAD behavior rating scale for demen-
(red.): Alzheimer s Disease and Related Disorders tia. Int. Psychogeriatr. 1996; 8 (supl. 3): 317-320.
Annual. Martin Dunitz Ltd. 2000: 179-198. 76. Davis K.L., Marin D.B., Kane R. i wsp.: The Care-
57. Tekin S., Mega M.S., Masterman D.M. i wsp.: Orbito- giver Activity Survey (CAS): development and valida-
frontal and anterior cingulate cortex neurofibrillary tion of a new measure for caregivers of persons with
tangle burden is associated with agitation in Alzhei- Alzheimer s disease. Int. J. Geriatr. Psychiatry 1997;
mer disease. Ann. Neurol. 2001; 49: 355-361. 12: 978-988.
58. Farber N.B., Rubin E.H., Newcomer J.W. i wsp.: In- 77. Andreasen N., Hesse C., Davidsson P. i wsp.: Cerebro-
creased neocortical neurofibrillary tangle density in spinal fluid ²-amyloid(1-42) in Alzheimer disease differ-
subjects with Alzheimer disease and psychosis. Arch. ences between early- and late-onset Alzheimer dis-
Gen. Psychiatry 2000; 57: 1165-1173. ease and stability during the course of disease. Arch.
59. Mega M.S., Lee L., Dinov I.D. i wsp.: Cerebral corre- Neurol. 1999; 56: 673-680.
lates of psychotic symptoms in Alzheimer s disease. 78. Ishiguro K., Ohno H., Arai H. i wsp.: Phosphorylated
J. Neurol. Neurosurg. Psychiatry 2000; 69: 167-171. tau in human cerebrospinal fluid is a diagnostic marker
60. Tariot P.N., Blazina L.: The psychopathology of de- for Alzheimer s disease. Neurosci. Lett. 1999; 270: 91-94.
mentia. W: Morris J. (red.): Handbook of Dementing 79. Hulstaert F., Blennow K., Ivanoiu A. i wsp.: Improved
Illnesses. Marcel Dekker Inc., New York 1993: 461-475. discrimination of AD patients using beta-amyloid(1-42)
61. Rosenquist K., Tariot P., Loy R.: Treatments for be- and tau levels in CSF. Neurology 1999; 52: 1555-1562.
havioural and psychological symptoms in Alzheimer s 80. Teunissen C.E., de Vente J., Steinbusch H.W., De
disease and other dementias. W: O Brien J., Ames D., Bruijn C.: Biochemical markers related to Alzheimer s
dementia in serum and cerebrospinal fluid. Neurobiol. 99. Reiman E.M., Caselli R.J., Yun L.S. i wsp.: Preclinical
Aging 2002; 23: 485-508. evidence of Alzheimer s disease in persons homozy-
81. Knopman D.S., DeKosky S.T., Cummings J.L. i wsp.: gous for the epsilon 4 allele for apolipoprotein E.
Practice parameter: diagnosis of dementia (an evidence- N. Engl. J. Med. 1996; 334: 752-758.
based review). Report of the Quality Standards Sub- 100. Nagata K., Kondoh Y., Atchison R. i wsp.: Vascular
committee of the American Academy of Neurology. and metabolic reserve in Alzheimer s disease. Neuro-
Neurology 2001; 56: 1143-1153. biol. Aging 2000; 21: 301-307.
82. Post S.G., Whitehouse P.J., Binstock R.H. i wsp.: The 101. Nagata K., Sato M., Satoh Y. i wsp.: Hemodynamic
[ Pobierz całość w formacie PDF ]